Financial

Itamar Medical Reports Third Quarter 2021 Financial Results

– Revenues Increased 23% Year-over-Year to $13.6 Million – – U.S. WatchPAT™ Revenues Increased 27% Year-over-Year to $11.3 Million – CAESAREA, Israel, Nov. 18, 2021 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today reported unaudited financial results […]

Filterlex Medical Closes a $6Million Series A1 Investment to Accelerate the CAPTIS® Cardiovascular Clinical Program

CAESAREA, Israel, Nov. 18, 2021 /PRNewswire/ — Filterlex Medical, a cardiovascular medical device startup, announced today that it has recently completed a US $6 Million series A1 investment round from leading private healthcare investors. The financing will accelerate implementation of the company’s CAPTIS® clinical program. The CAPTIS is a next-generation, full-body embolic protection device to reduce […]

Zynex Ranked 7th in Revenue Growth Among Medical Device Companies

ENGLEWOOD, Colo., Nov. 18, 2021 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics today announced it has been ranked 7th in revenue growth among all medical device companies in the U.S. and Canada on Deloitte’s 2021 […]

Aerami Therapeutics Appoints Barry Deutsch as Chief Financial Officer

DURHAM, N.C., Nov. 18, 2021 (GLOBE NEWSWIRE) — Aerami Therapeutics, Inc. (the “Company”), a leader in the field of developing inhaled therapies to treat severe respiratory and chronic diseases, today announced the appointment of Barry Deutsch as chief financial officer effective November 15, 2021. “Barry is a seasoned financial executive who brings […]

HeartBeam Announces Closing of Initial Public Offering

SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology to bring new capabilities to cardiovascular disease, today announced the closing of its underwritten initial public offering of 2,750,000 units, each consisting of (i) one share of common stock and (ii) […]

Renovacor Announces Third Quarter 2021 Financial Results and Provides Corporate Update

Debuted as a public company and strengthened liquidity position with $95.1 million in gross proceeds from the business combination with Chardan Healthcare Acquisition 2 Corp and concurrent PIPE financing Released topline preclinical data demonstrating feasibility of REN-001 to transduce a large animal heart via local infusion at low vector doses […]

Tenax Therapeutics Reports Third Quarter 2021 Results and Provides Business Update

MORRISVILLE, N.C.–(BUSINESS WIRE)–Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical need, today reported financial results for the third quarter of 2021 and provided a business update. “As we approach the new year, […]

Abbott Achieves Highest Score in Its Industry for the Ninth Consecutive Year on the Dow Jones Sustainability Index (DJSI)

– Abbott included on DJSI for 17 consecutive years for strong environmental, social and governance (ESG) performance – Top score in the Health Care Equipment & Supplies sector reflects Abbott’s 2030 Sustainability Plan focus on innovating for greater access to life-changing technologies and breaking down barriers to health equity ABBOTT […]